Krema H - Search Results

1

Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.

Salama Y, Albanyan S, Szybowska M, Bullivant G, Gallinger B, Giles RH, Asa S, Badduke C, Chiorean A, Druker H, Ezzat S, Hannah-Shmouni F, Hernandez KG, Inglese C, Jani P, Kaur Y, Krema H, Krimus L, Laperriere N, Lichner Z, Mete O, Sit M, Zadeh G, Jewett MAS, Malkin D, Stockley T, Wasserman JD, Xu W, Schachter NF, Kim RH. Salama Y, et al. Among authors: krema h. Clin Genet. 2019 Nov;96(5):461-467. doi: 10.1111/cge.13613. Epub 2019 Aug 6. Clin Genet. 2019. PMID: 31368132

2

Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up.

Krema H, Somani S, Sahgal A, Xu W, Heydarian M, Payne D, McGowan H, Michaels H, Simpson ER, Laperriere N. Krema H, et al. Br J Ophthalmol. 2009 Sep;93(9):1172-6. doi: 10.1136/bjo.2008.153429. Epub 2009 May 3. Br J Ophthalmol. 2009. PMID: 19414441

3

Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: histopathologic and dosimetric findings.

Fernandes BF, Weisbrod D, Yücel YH, Follwell M, Krema H, Heydarian M, Xu W, Payne D, McGowan H, Simpson ER, Laperriere N, Sahgal A. Fernandes BF, et al. Among authors: krema h. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):377-84. doi: 10.1016/j.ijrobp.2010.04.073. Epub 2010 Sep 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 20864264

4

Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.

Krema H, Xu W, Payne D, Vasquez LM, Pavlin CJ, Simpson R. Krema H, et al. Can J Ophthalmol. 2011 Apr;46(2):158-63. doi: 10.3129/i10-111. Can J Ophthalmol. 2011. PMID: 21708084

5

Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.

Krema H, Heydarian M, Beiki-Ardakani A, Weisbrod D, Xu W, Laperriere NJ, Sahgal A. Krema H, et al. Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):510-5. doi: 10.1016/j.ijrobp.2013.02.005. Epub 2013 Mar 16. Int J Radiat Oncol Biol Phys. 2013. PMID: 23507292

6

Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma.

Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Krema H, et al. Br J Ophthalmol. 2013 Jun;97(6):730-4. doi: 10.1136/bjophthalmol-2012-302991. Epub 2013 Mar 26. Br J Ophthalmol. 2013. PMID: 23532618

7

Unusual orange-colored choroidal metastases.

Krema H, McGowan H, Tanzer H, Simpson R, Laperriere N. Krema H, et al. J Ophthalmic Vis Res. 2013 Jan;8(1):53-7. J Ophthalmic Vis Res. 2013. PMID: 23825713 Free PMC article.

8

Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival.

Hahn E, Laperriere N, Krema H, Velazquez-Martin JP, Somani S, Waldron J, Simpson R, Payne D, Chung C. Hahn E, et al. Among authors: krema h. Pract Radiat Oncol. 2017 Nov-Dec;7(6):388-395. doi: 10.1016/j.prro.2017.06.012. Epub 2017 Jun 29. Pract Radiat Oncol. 2017. PMID: 28867543 Clinical Trial.

9

Cauda equina syndrome as the initial presentation of uveal melanoma metastasis.

Hanout M, Kamil ZS, Alrjoub M, Laperriere N, Altomare F, Krema H. Hanout M, et al. Among authors: krema h. Eur J Ophthalmol. 2022 Jan;32(1):NP1-NP4. doi: 10.1177/1120672120944799. Epub 2020 Jul 22. Eur J Ophthalmol. 2022. PMID: 32700563

10

Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma.

Soliman SE, Bansal A, De Nicola ML, Bhambhwani V, Laperriere N, Gallie BL, Krema H. Soliman SE, et al. Among authors: krema h. Can J Ophthalmol. 2021 Oct;56(5):317-324. doi: 10.1016/j.jcjo.2020.12.016. Epub 2021 Jan 23. Can J Ophthalmol. 2021. PMID: 33493457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page